Gelfand M J, Smith H S, Ryckman F C, Balistreri W F, Specker B, Caron K H, Pedersen S H
Department of Radiology, Children's Hospital Medical Center, Cincinnati, Ohio 45229-2899.
Clin Nucl Med. 1992 Jul;17(7):542-9. doi: 10.1097/00003072-199207000-00002.
The clinical usefulness of hepatobiliary scintigraphy was evaluated in pediatric liver transplant recipients. One hundred fifteen hepatobiliary scintigraphic studies were performed in 30 patients who received 22 whole liver and 16 segmental grafts. Parameters that were useful in predicting an adverse outcome were failure to visualize excreted radiopharmaceutical at or beyond the biliary anastomosis on a study performed within 24 hours after transplant, and persistent or increasing delay in the time of visualization of excreted radiopharmaceutical. Abnormalities of liver uptake and excretion were seen in rejection, but they were also seen in patients who remained well without rejection or parenchymal disease. Significant biliary leaks were identified in the three cases in which they were known to be present. In liver transplant recipients, hepatobiliary imaging is useful in predicting graft survival and identifying biliary leaks.
对小儿肝移植受者的肝胆闪烁显像的临床实用性进行了评估。对30例接受了22例全肝移植和16例节段性移植的患者进行了115次肝胆闪烁显像研究。在移植后24小时内进行的一项研究中,未能在胆道吻合口或其远端观察到放射性药物排泄,以及放射性药物排泄的显像时间持续或增加延迟,这些参数有助于预测不良结局。在排斥反应中可见肝脏摄取和排泄异常,但在未发生排斥反应或实质性疾病且情况良好的患者中也可见到。在已知存在重大胆漏的3例病例中发现了胆漏。在肝移植受者中,肝胆显像有助于预测移植物存活并识别胆漏。